Stanford Stroke Center News and Events
Hospitals across the United States are seeing fewer stroke patients coming to their facilities for care — and a new paper ties that trend to the coronavirus pandemic. The paper, published Friday in the New England Journal of Medicine as a letter to the editor, suggests that the number of patients in the United States undergoing imaging for stroke evaluation has decreased by 39% since before the pandemic
Study aims to learn more about silent infarction, cognitive decline linked to silent stroke
Can you have a stroke and not know it? Unfortunately, yes. It is a phenomenon called a silent stroke or, more formally, a silent cerebral infarction. Investigators at the University of Alabama at Birmingham and Stanford University want to learn more about silent strokes and their role in brain health, including dementia.
Stanford Stroke Center beats national stroke treatment times
During a stroke, 1.9 million neurons die every minute. Stanford Health Care cut half an hour off its stroke treatment time, helping patients.
Vascular Dementia Treatment: How Lifestyle Changes Are Key to Prevention
According to the Alzheimer’s Association, vascular dementia is the second most common cause of dementia but it can be difficult to diagnose. Dr. Marion Buckwalter, associate professor of neurology and neurosurgery, discusses possible causes and how to reduce the risk of getting dementia.
Researchers building glove to treat symptoms of stroke
Strokes often have a devastating impact on our hands. Now, Stanford researchers are collaborating on a vibrating glove that could improve hand function after a stroke.
Stanford Young Stroke Program
The Stanford Young Stroke Program is one of a few major programs in the US and the only one on the West Coast dedicated to stroke prevention, diagnosis, treatment, and rehabilitation specifically for young patients.
Time: The huge game changer for treatment of stroke, a podcast
Albers, director of the Stanford Stroke Center, has been working to understand the mechanisms governing strokes for nearly 30 years. Thanks to that dogged work, Albers hit gold in 2018 with the release of data from a large multisite clinical trial, DEFUSE 3.
Like Luke Perry, John Singleton’s crisis shows that strokes happen ‘at any age’
While it is true that the vast majority of people who suffer a stroke in the United States are 65 and older, “strokes can happen at any age."
Strokes often have a devastating impact on something most of us rely heavily on in our daily lives – our hands. Now, Stanford researchers are collaborating on a vibrating glove that could improve hand function after a stroke.
Stanford researchers have found that transient changes in the numbers and activation levels of a handful of circulating immune cell types can predict the likelihood of dementia one year after a stroke.
Researchers like Marion S. Buckwalter, MD, PhD and her colleague Maarten Lansberg, MD, PhD are working on how to prevent dementia in stroke survivors, nearly half of whom develop the condition in the first decade after a stroke. Others are working on new ways to deliver drugs right where they're needed in the brain, developing ways to stimulate the brain's recovery with magnetic fields, and building robotic devices tailored to help individual stroke patients walk more easily. With those and other developments on the horizon, the future for stroke survivors could be bright.
In a multicenter study led by Stanford researchers, the number of stroke patients who died or required confinement to nursing homes was nearly cut in half, the biggest improvement seen in any stroke-related trial to date.
Advanced brain imaging technology may give doctors an additional 10 hours or more to respond to some strokes, researchers said Wednesday, a development that may soon bring major changes to the way hospitals treat one of the leading causes of disability and death.
Advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed, according to a new study.
We conducted a multicenter, randomized, open-label trial, with blinded outcome assessment, of thrombectomy in patients 6 to 16 hours after they were last known to be well and who had remaining ischemic brain tissue that was not yet infarcted.
Clinical trial shows broader benefits of acute-stroke therapy iSchemaView RAPID software plays central role in success
DEFUSE 3, a 38-center clinical trial sponsored by the National Institutes of Health and led by Stanford researchers, has shown that far more people than previously thought can benefit from existing emergency treatments for acute ischemic stroke.
Stanford Health Care announced that it has been recertified by The Joint Commission as an Advanced Comprehensive Stroke Center, a prestigious designation reserved for institutions with specific abilities to receive and treat the most complex stroke cases.
Treatment for stroke is determined by the stopwatch. Missing the few hours that are the window of opportunity between stroke onset and the time of diagnosis make many patients ineligible for reperfusion therapy
Why is the risk for developing dementia doubled for as much as a decade after stroke? A new study suggests the answer may be B cells.
Study ties immune cells to delayed onset of post-stroke dementia
Researchers say that the appearance in the brain of a type of immune cell has been implicated in delayed dementia in mice and humans who have suffered a stroke.
Public policies for addiction, smarter prosthetics and stroke among the Big Ideas tackled by Stanford neuroscientists
Brain research that improves policies for treating drug addiction is one of seven Big Ideas that will become new priorities for the Stanford Neurosciences Institute. These new interdisciplinary teams span schools and disciplines to tackle critical challenges in brain research.
With financial support from the Big Ideas in Neuroscience program, Maarten Lansberg, MD, PhD, and Marion Buckwalter, MD, PhD, have merged their basic science and clinical backgrounds, pulled in experts from across Stanford and built a collaborative network of brain power to tackle this essential question: Why do some patients recover better from stroke while others do not? The Stroke Collaborative Action Network, or SCAN, was developed to understand the mechanisms of stroke recovery and to enhance recovery through new treatments.
Nov November 12 - 13 Thu-Fri 2020
10th Annual Breakthroughs in Neurologic Therapies
May 3, 2017: Stanford Health Care announced that it has been recertified by The Joint Commission as an Advanced Comprehensive Stroke Center, a prestigious designation reserved for institutions with specific abilities to receive and treat the most complex stroke cases.
Rethinking neurorehabilitation of stroke
John W. Krakauer
John C Malone Professor
Professor, Neurology & Neuroscience
Johns Hopkins University School of Medicine
Date: May 20, 2016
Description: Dr. Krakauer received his bachelor and master deegree from Cambridge University, and his medical degree from Columbia University College of Physicians and Surgeons where he was elected to Alpha Omega Alpha Medical Honor Society. After completing an internship in Internal Medicine at The Johns Hopkins Hospital, he returned to Columbia University for his residency in Neurology at the Neurological Institute of New York. He subsequently completed a research fellowship in motor control in the Center of Neurobiology and Behavior at Columbia and a clinical fellowship in stroke at the Neurological Institute at Columbia University Medical Center. He is currently Professor of Neurology and Neurological Sciences at Johns Hopkins University School of Medicine where he directs the Brain, Learning, Animation, and Movement Lab (BLAM). He is a neurologist who sees patients with stroke and other cerebrovascular diseases. His research investigates motor control and learning in people, stroke recovery, and neuro-rehabilitation.
This event is sponsored by Stanford Neurosciences Institute Big Ideas Brain Machine Interface and SCAN
Rebuilding the Brain After Stroke, World Economic Forum
Dr. Buckwalter spoke about the SCAN project at the World Economic Forum in January 2015. She talked about the importance of stroke as a global health problem and the importance of collaboration between disciplines to solve the problem of how stroke recovery works, and described how SCAN scientists are working together to develop treatments for stroke survivors.